|
Gomez-Peralta F, Menendez E, Conde S, Conget I, Novials A; investigators of the studies SED and SED1. Clinical characteristics and management of type 1 diabetes in Spain. The SED1 study. Endocrinol Diabetes Nutr (Engl Ed). 2021 Nov;68(9):642-653. doi: 10.1016/j.endien.2021.11.020. Epub 2021 Dec 3. PubMed PMID: 34906345.
AÑO: 2021; IF: 1.833
|
34906345
|
Garcia Zafra V, Hernandez Torres A, Garcia Vazquez E, Soria Cogollos T, Canteras Jordana M, Ruiz Gomez J, Gomez Gomez J, Hernandez Martinez A, Barberan J. Risk factors for methicillin-resistant Staphylococcus aureus and extended-spectrum ss-lactamase producing Enterobacterales in patients with diabetic foot infections requiring hospital admission. Rev Esp Quimioter. 2020 Dec;33(6):430-435. doi: 10.37201/req/101.2020. Epub 2020 Nov 27. PubMed PMID: 33246358; PubMed Central PMCID: PMC7712337.
AÑO: 2020; IF: 1.553
|
|
Del Carmen Asensio Lopez M, Lax A, Hernandez Vicente A, Saura Guillen E, Hernandez-Martinez A, Fernandez Del Palacio MJ, Bayes-Genis A, Pascual Figal DA. Author Correction: Empagliflozin improves post-infarction cardiac remodeling through GTP enzyme cyclohydrolase 1 and irrespective of diabetes status. Sci Rep. 2020 Oct 9;10(1):17266. doi: 10.1038/s41598-020-73065-5. PubMed PMID: 33037250; PubMed Central PMCID: PMC7547718.
AÑO: 2020; IF: 4.379
|
|
Ruiz J, Rios A, Rodriguez JM, Paredes M, Soriano V, Oviedo MI, Hernandez AM, Parrilla P. Incidental versus clinical diagnosis of papillary thyroid microcarcinoma. Long-term prognosis. Endocrinol Diabetes Nutr (Engl Ed). 2020 May;67(5):317-325. doi: 10.1016/j.endinu.2019.09.012. Epub 2019 Dec 24. English, Spanish. PubMed PMID: 31882257.
AÑO: 2020; IF: 1.417
|
|
Ruiz-Pardo J, Rios-Zambudio A, Rodriguez-Gonzalez JM, Paredes-Quiles M, Soriano-Gimenez V, Oviedo-Ramirez MI, Hernandez-Martinez AM, Parrilla-Paricio P. Results of treatment of papillary thyroid microcarcinoma adapted to risk of recurrence. Cir Cir. 2020;88(5):576-583. doi: 10.24875/CIRU.20001560. PubMed PMID: 33064693.
AÑO: 2020; IF: 0.361
|